New Approaches to Metabolomics Research

Slides:



Advertisements
Similar presentations
David M. Pollock Medical College of Georgia Discovery-Academia.
Advertisements

Road to Independence Bill Fay, MD University of Missouri FINANCIAL DISCLOSURE: No relevant financial relationships exist.
Integrative Organs Systems Scientists and Drug Discovery: The Link Between Big Pharma and Academia Glenn A. Reinhart, Ph.D. Senior Group Leader Integrative.
“It is the responsibility of those of us involved in today’s biomedical research enterprise to translate the remarkable scientific innovations we are witnessing.
Connecting the Technopark to the Incubator Association of University Research Parks, 2012 © Harold Strong, AURP Immediate Past President Director of Discovery.
Brian C. Springer, MHA Executive Director Siteman Cancer Center Barnes-Jewish Hospital & Washington U. School of Med CCSG-CTSA Interactions Michael Bertram,
Bindley Bioscience Center Vision: Nurture interactive communication and interdisciplinary discovery with flexible laboratory project spaces and an open.
Harvard Catalyst: How Can It Help Your Research? Steven D. Freedman MD PhD Professor of Medicine, HMS Associate Dean for Clinical and Translational Research,
National Institute on Aging Richard J. Hodes, M.D. Director,NIA/NIH/DHHS ADC Meeting – NIH Roadmap and Budget October 2003.
Clinical and Translational Science Award (CTSA) John F. Ennever Medical Director, CTO Director, RKSR.
MINORITY OPPORTUNITIES IN RESEARCH NATIONAL INSTITUTES OF HEALTH NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES Division of Minority Opportunities in Research.
School of Medicine Shared Resource Facilities The School of Medicine provides direct support and oversight to 21 SOM shared resource facilities. Their.
The South African Malaria Initiative A Case Study E Jane Morris Bridging the Gap in Global Health Innovation - from Needs to.
UAMS CENTER FOR CLINICAL & TRANSLATIONAL RESEARCH (CCTR) CCTR Novel Methodologies UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES uams.edu/cctr Curtis L. Lowery,
1 Harvard Postgraduate Educational Program in Clinical/Translational Science Presentation to ETEC May 6, 2009.
U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Neurological Disorders and Stroke U.S. DEPARTMENT OF HEALTH.
Figure 4.1 NEW PRODUCT DEVELOPMENT PROCESS Finance Corporate strategy and portfolio decisions Regulatory affairs Marketing and sales + market research.
Johns Hopkins Technology Transfer 1 Translational Biomedical Research: Moving Discovery from Academic Centers to the Community Translational Biomedical.
Wishwa N. Kapoor, MD, MPH, Director Doris M. Rubio, PhD, Co-Director Multidisciplinary Clinical Research Scholars Program.
Image 1 – Tomato seedling iStockphoto/Thinkstock, Image 2 – Fermenter iStockphoto/Thinkstock 2011, Image 3 – Wheat Hermerara/Getty Images, Image 4 –DNAConfig.
Probe into Discovery and Translational Service in Creative BioMart
Indiana Institute For Personalized Medicine David A Flockhart MD, PhD Professor of Medicine, Genetics and Pharmacology Indiana University.
Center for Excellence in Research “Managing a Scientific Laboratory” Navigating the University M. Elizabeth Fini, PhD Director, USC Institute for Genetic.
IndianaCTSI ACCELERATING CLINICAL AND TRANSLATIONAL RESEARCH The Indiana CTSI HUB Bill Barnett Director, Information Infrastructures, Indiana CTSI
1 G. P. S. Raghava Institute of Microbial Technology, Chandigarh.
West Virginia Clinical Translational Science Institute Links Scientists and Teachers Sara Hanks, Ann Chester, Summer Kuhn.
U-BIOPRED (Unbiased BIOmarkers in PREDiction of respiratory disease outcomes) → a 5-year European project to understand more about severe asthma Update:
The “Analysome” Unmet Need  Drug R&D requires validated biomarker assays  Information on such assays is available but is neither well coordinated nor.
CTSA Imaging Working Group Coordinated by: RSNA (Radiologic Society of North America) DTRI (Duke Translational Research Institute)
The Need for Regulatory Science April 15, 2013 Judith A. Britz, PhD Executive Director, BioMaryland Center.
The FDA: Basic Facts It takes 12 to 15 years to develop a single drug Only 1 in 10,000 potential medications makes it completely through the process Only.
National Center for Research Resources G. Iris Obrams, M.D., M.P.H., Ph.D. NCRR Update 5 August 2006.
Transforming the CTRI and UCSD: From Silo to Collaboration Gary S. Firestein, M.D.
Robert H. Wiltrout Director, CCR Director’s Address.
Wishwa N. Kapoor, MD, MPH, Director Doris M. Rubio, PhD, Co-Director Multidisciplinary Clinical Research Scholars Program.
Why Write A Grant? Elaine M. Hylek, MD, MPH Professor of Medicine Associate Director, Education and Training Division BU CTSI Section of General Internal.
MRC Technology an independent life science medical research charity Biotech & Money 2016 Mr Andrew Mercieca, Director of Finance
Biostatistics, Epidemiology, and Research Design (BERD) PAUL NIETERT, PHD SCTR LUNCH-N-LEARN DECEMBER 9, 2015.
ICTR Biostatistics Research Resource Mary Lindstrom Professor, Dept. of Biostatistics and Medical Informatics Director, ICTR Biostatistics Research Resource.
NCI Division of Cancer Prevention Ongoing Activities at Frederick Facilities Presented By: Lori Minasian, M.D. Robert Shoemaker, Ph.D. October 1, 2015.
1 Extending the Wisconsin Idea UW Funding Opportunities for Technologies with Promising Potential.
Synthetic Chemistry for the Life Sciences Dial – a – Molecule Workshop, University of Liverpool Jan-12 Where / how can chemistry make greater contribution.
11/21/2014 CFAR Mentoring Core Facilities at UCSF and Beyond Teri Liegler, PhD Director ARI-UCSF Laboratory of Clinical Virology CFAR Virology Core Laboratory.
Created by BM|DESIGN|ER SigniPhi SAAS to biomarker discovery stage 1 - SAAS Stage 2 - partner Stage 3 - biomarker discovery.
Mark Garcia Administrative Director, Institute for Clinical and Translational Research.
OFFICE OF THE VICE PRESIDENT FOR RESEARCH
Mission Davenport University prepares and transforms students to achieve the highest levels of academic performance, leading them to excel and advance.
Translational Research Why should you care about translational research? The public cares. Translation into therapies justifies spending on science.
MRC’s Translational Research Funding
Jocelyn Rose Director, Center for Life Science Enterprise.
Novartis Pediatric Drug Development Faculty Program
TRI Resources for Researchers
ATOM Accelerating Therapeutics for Opportunities in Medicine
Nicholas P. Ambulos, PhD Director, CIBR October 24, 2017
SCTR Scientific Retreat on Aging Related Research
From Bench to Clinical Applications: Money Talks
Opportunities to Pursue a Clinical and Translational Career at Penn Emma A. Meagher, MD Vice Dean for Clinical Research & Chief Clinical Research Officer.
Office of Human Subjects Research
Department of Medicine Michael Farkouh, Vice-Chair Research michael
Rick McGee, PhD and Bill Lowe, MD Faculty Affairs and NUCATS
Information Session January 18, :00-1:45 pm
An Investigator’s Guide to the Clinical and Translational Science Awards and the Trial Innovation Network (TIN)  What can we do for you? May 2017.
What is CICATS? The University of Connecticut, in partnership with regional hospitals, state agencies, and community health care organizations, has.
Clinical and Translational Science Awards Program
Standards Development for Metabolomics
Clinical and Translational Science Scholars Program
Pillars of WARF Therapeutics: Invest - Develop - Partner
OUR HISTORY & MISSION ABOUT US. OUR HISTORY & MISSION ABOUT US.
Considerations for Successful Biopharmaceutical Product Development: Discovery to Proof of Concept -A Panel Discussion Stanley C. McDermott, PharmD, MS,
Center for Clinical and Translational Science
Presentation transcript:

New Approaches to Metabolomics Research Institute for Clinical and Translational Research And Translational Laboratory Cores Craig Hendrix, MD, ICTR/CFAR Lab Core Director chendrix@jhmi.edu, 410-955-9707 Curt Reynolds, MAS, ICTR/CFAR Lab Core Project Manager cjreyn@jhmi.edu, 443-287-3060

What can ICTR do for you? http://ictr.johnshopkins.edu/ Organized into 6 Cores Translational Laboratory Core (TLC) Human Subjects Research Core Quantitative Methodologies Core Informatics Core Research Participant and Community Partnership Core Education, Training and Career Development Core …and 2 stand-alone programs The Studio/Navigation Program Translational Research Communities

Pilot Funding http://ictr.johnshopkins.edu/ Objective: Targeted Funding & Engaged Management to Advance Translational Research Accelerated Translational Incubator Program (ATIP) Funding requests one to two times per year. Approximately 5-10 awards made per year. Awards up to $100,000 in direct costs (no salary support) 12-month accelerated funding period Nexus Awards Gap targeted RFA from each Research community Biomarker and Diagnostic Testing Drugs/Biologics/Vaccines/Devices Behavioral, Social, and Systems Science Funding/timing similar to ATIP

Pilot Funding http://ictr.johnshopkins.edu/ Doris Duke Early Clinical Investigator Award 1 – 2 years of funding of $30,000 – 40,000 per year to fund salary or other research support needs Comprehensive support program that integrates supplemental financial resources with guidance for career development services, and ongoing mentoring. Support may include: Salary support for research coordinator, biostatistician, data base specialist, help with access to clinical data, writer; Salary support to allow more research time (e.g., reduce clinical obligations) SOM Discovery Fund For Synergy and Innovation Award Provide grant awards to cross-divisional teams, comprised of faculty and/or non-faculty members from at least two schools or affiliates of the university, who are poised to arrive at important discoveries or creative works. The expectation is that these awards will spark new, synergistic interactions between investigators across the institution and lead to work of the highest quality and impact.

Translational Laboratory Core (TLC) Provide state-of-the-art conceptual and technical laboratory support Deliver services to translational scientists Priority to ATIP developmental grants, junior, and new translational scientists 11 service core laboratories provide: Consultation Assay development Sample analysis Coordination with ICTR Clinical Services, Studios, Communities Costs subsidized; depend on investigator funding

TLC Laboratories Drug Development Resources & Services Drug Analysis Units Assay development, sample analysis, pharmacokinetics, pre-clinic study design Oncology Michelle Rudek , (mrudek2@jhmi.edu, 443-287-6476) Clinical Pharmacology Analytical Lab (CPAL) Mark Marzinke (mmarzin1@jhmi.edu, 410-502-7691) Medicinal Chemistry Unit David Meyers (dmeyers7@jhmi.edu , 410-502-4804) Small molecule synthesis, supports structure-activity relationship studies Drug Screening Library Unit Jun Liu (joliu@jhu.edu, 410-955-4619) FDA approved drug library; repurposing licensed drugs

TLC Laboratories Drug Development Resources & Services (Continued) Johns Hopkins Drug Discovery Research Consultancy and Services Barbara Slusher (bslusher@jhmi.edu, 410-614-0662) Offers consultants based on 18 years of Pharma industry experience. The program has interactions and connections with the pharma, biotech and venture community. Medicinal Chemistry Unit: Takashi Tsukamoto Assay development Unit: Camilo Rojas Drug Metabolism & Pharmacokinetics Unit: Rana Rais In vivo Pharmacology Unit: Krystyna Wozniak Drug Development Unit Craig Hendrix (chendrix@jhmi.edu, 410-955-9707) Consultative support for early clinical drug development Protocol design, data analysis, clinical study support

TLC Laboratories Biologics Vic Lemas, Ruth Karron (mvlemas@jhmi.edu , 410-614-5411, rkarron1@jhu.edu, 410-614-0319) Biologic product development/testing, GMP cell lines, gene vectors, antibodies, peptides Proteomics Robert Cole (rcole@jhmi.edu, 410-614-6968) Profiling for small molecules, biomarker development, protein analysis Metabolomics Anne Le (annele@jhmi.edu, 410-955-9297) Analysis of endogenous small molecules, targeted mass spec-based metabolomics Genetics Garry Cutting (gcutting@jhmi.edu, 410-955-1773) Genetic based sequencing and diagnostic assays, Clinical assay development Imaging Kasia Macura (kmacura@jhmi.edu, 410-955-6500) Facilitates integrated use of imaging resources, image data file storage, & distribution CRU Core Laboratory Neal Fedarko (ndarko@jhmi.edu, 410-550-2632) Kit-based assays validated, applied to support clinical studies

On The Web - Information http://ictr.johnshopkins.edu Click on Laboratory Services